The Biodistribution of Technetium-99m Labeled Glucose ~(99)Tc~m-Ec-dg in S180 Sarcoma Tumor-bearing Mice

Jie Chen
2005-01-01
Abstract:Objective To evaluate the biodistribution of techntium-99m labeled glucose ~(99)Tc~m-EC-DG in S180 Sarcoma tumor-bearing mice. Methods Fourty eight S180 sarcoma tumor-bearing mice were divided into 8 groups and fasted more than 8 hours before the injection of ~(99)Tc~m-EC-DG.Five minutes,15 minutes, 30 minutes, l hour, 2 hours,4 hours, 8 hours and 24 hours after the injection of 3.7 MBq ~(99)Tc~m-EC-DG,these mice were sacrificed by cutting the carotid.Selected tissues were excised and weighed, and the radioactivity was measured.The biodistrbution of radiotracer in each tissue was calculated as per percentage of the injected dose per gram of wet tissue weight (%ID/g).The ratio of tumor to blood, tumor to muscle, tumor to lung and tumor to liver were calculated. Meanwhile , 5 tumor-bearing mice were imaged after the injection of 18.5 MBq ~(99) Tc~m-EC-DG at the same time. Result The radioactivity ratio of tumor to blood, tumor to muscle, tumor to lung and tumor to liver increased after the injection, and all exceeded 1.0 at the 4th hour after injection. The imaging results were that same as that provided by biodistribution data, the radioactivity of tissues around tumor were decreased gradually after injection,and the tumor focus was clearly visualized at the 4th hour after injection.Conclusion ~(99)Tc~m-EC-DG can be used as an imaging agent of tumor glucose metabolism.
What problem does this paper attempt to address?